4//SEC Filing
Sassi Nir 4
Accession 0001641172-25-003826
CIK 0001857044other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:15 PM ET
Size
18.5 KB
Accession
0001641172-25-003826
Insider Transaction Report
Form 4
Sassi Nir
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.07/sh−2,500$177→ 0 totalExercise: $72.00From: 2019-09-13Exp: 2026-09-13→ Common Stock (2,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.07/sh−41$3→ 0 totalExercise: $331.20From: 2016-03-27Exp: 2026-03-27→ Common Stock (41 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.07/sh−1,125$80→ 0 totalExercise: $610.24From: 2019-01-22Exp: 2026-01-22→ Common Stock (1,125 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.07/sh−1,250$89→ 0 totalExercise: $25.72From: 2020-09-16Exp: 2027-09-16→ Common Stock (1,250 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.07/sh−500$36→ 0 totalExercise: $357.28From: 2016-07-25Exp: 2026-07-25→ Common Stock (500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.07/sh−500$36→ 0 totalExercise: $357.28From: 2016-07-25Exp: 2026-07-25→ Common Stock (500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.07/sh−1,125$80→ 0 totalExercise: $34.32From: 2020-02-17Exp: 2027-02-17→ Common Stock (1,125 underlying)
Footnotes (1)
- [F1]The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001760673
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:15 PM ET
- Size
- 18.5 KB